Hyperlipidemias Completed Phase 1 Trials for Amlodipine (DB00381)

Also known as: Hyperlipidemia / Hyperlipemia / Hyperlipidaemia / Hyperlipaemia / Hyperlipidemia, unspecified / Lipidemia / Hyperlipidaemia NOS

IndicationStatusPhase
DBCOND0031916 (Hyperlipidemias)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03009474Pharmacokinetics Study of CJ-30060 After Single Dose Administration in Health Male VolunteersTreatment
NCT03116516Clinical Trial to Compare the Safety and Pharmacokinetics of YHP1604 in Comparison to the Co-administration of Telmisartan/Amlodipine and RosuvastatinTreatment
NCT03657472Bioequivalence Study of CJ-30061 in Healthy Male VolunteersBasic Science
NCT02387619The Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan/AmlodipineTreatment
NCT02569814A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/RosuvastatinTreatment
NCT02951962A Study to Investigate Pharmacokinetic Drug Interaction and Safety of Telmisartan/Amlodipine and RosuvastatinTreatment